DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Credit Suisse Maintains Outperform on Abbott Laboratories, Lowers Price Target to $94

Credit Suisse maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from $104 to $94.

Benzinga · 03/06/2020 15:38

Credit Suisse maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from $104 to $94.